Inquiry
Tell us about your condition. Speak with our medical advisors — no obligation.
by Beike Biotechnology
Specialized adult stem cell protocols for neurological and degenerative conditions — refined over two decades, delivered by an internationally accredited medical team.
Since 2005 we have focused on treatment protocols for conditions like cerebral palsy, ataxia and spinal cord injury — combining multiple stem cell injections with an intensive rehabilitation program. For many neurological, neuromuscular and autoimmune conditions, this offers a real chance of measurable improvement.
Stem cell therapy is a form of regenerative medicine that delivers stem cells by injection. Stem cells are undifferentiated cells that can help repair tissue, regulate the immune system and stimulate the body’s own repair processes — in short, helping to regenerate cellular damage.
Tailored treatment programs for neurological, neuromuscular and degenerative conditions — built on two decades of clinical experience.
Stem cell therapy targets the root causes of joint degeneration in osteoarthritis — stimulating cartilage repair, reducing inflammation and improving mobility, rather than only masking the pain. See what our regenerative protocol can offer.
Stem cell protocol →Patients with SCA, Friedreich's ataxia and acquired forms have regained balance, speech and walking through our combined stem-cell and rehabilitation protocol. See what's possible.
Stem cell protocol →Stem cells, transcranial magnetic stimulation and microbiome therapy in one protocol — designed to address what's behind the behaviors, not just the behaviors themselves. See real patient stories.
Stem cell protocol →Hundreds of children with cerebral palsy have improved spasticity, balance, speech and motor control through our two-week protocol.
Stem cell protocol →Mesenchymal stem cells used to slow ALS and PLS progression — addressing the inflammation in the central nervous system, not just the symptoms. Patient stories inside.
Stem cell protocol →Mesenchymal stem cells that regulate the immune attack and support remyelination — beyond what conventional MS medications can offer. See published outcomes.
Stem cell protocol →Patients with Duchenne, Becker and other forms of MD have seen increased muscle mass, fewer respiratory infections and clinical stabilization. See how our protocol works.
Stem cell protocol →Stem cells delivered directly to the optic nerve, not just systemically. See what visual recovery has been documented in patients with optic nerve atrophy.
Stem cell protocol →Stem cells delivered directly to the optic nerve via retrobulbar and intrathecal injection. See visual and developmental gains documented in past optic nerve hypoplasia patients.
Stem cell protocol →A combined optic-nerve and hormonal condition treated with targeted stem cell delivery. See visual, developmental and endocrine improvements documented in past septo-optic dysplasia patients.
Stem cell protocol →Beyond surgical closure: stem cells targeting the spinal lesion to rebuild muscle strength, sensation and continence. See documented improvements in past patients.
Stem cell protocol →Stem cells delivered intrathecally — directly into the spinal canal where the lesion is — paired with intensive rehabilitation. See how patients regained function.
Stem cell protocol →Mesenchymal stem cells targeting the spinal cord, daily rehabilitation rebuilding what was lost. See documented outcomes from past SMA patients.
Stem cell protocol →Stem cells targeting the original brain lesion — not just rehabilitating around it. See how stroke patients regained motor and speech function.
Stem cell protocol →Catching the secondary wave of damage that conventional treatment can't prevent. Stem cells regenerating injured cells and limiting further inflammation. See patient outcomes.
Stem cell protocol →

We work with adult stem cells from two perinatal sources: umbilical cord blood and umbilical cord tissue, donated by healthy mothers after normal births. After reviewing your full medical history, our doctors recommend the source — and protocols may combine more than one type depending on your condition.
Cells are prepared in internationally accredited laboratories with full in-house control over processing and quality. No embryonic and no fetal cells — only ethically sourced adult stem cells, screened and quantified before a single dose is administered.
Stem cells alone don't heal. The protocol around them does — and ours has been refined over twenty years.
No embryonic, no fetal cells. Sourced ethically from umbilical cord donations.
Several delivery methods per session — IV, intrathecal, intramuscular — for maximum reach.
Stem cells repair tissue. Targeted physical therapy retrains the body to use it.
We track outcomes for months, not days. Your progress informs every patient that follows.
A Comprehensive Timeline · 1868 – 2026
Stem cell therapy has become a beacon of hope, offering treatments for conditions once deemed untreatable. These breakthroughs are not the product of recent discoveries but the result of over a century of scientific advancement — from the first use of the term “stem cell” in 1868 to today's regenerative therapies.
Explore the full timelineNo promises — only documented experiences from patients and their families, in writing and in their own words.
Pola's family researched stem cell treatment online and reached out to Beike to explore it as a potential option for their daughter. Although stem cell therapy is available in Poland, they found Beike’s approach more advanced. During their initial visit, they were impressed by the high level of care and the welcoming atmosphere at the clinic, where Pola underwent multiple therapies. The treatment addressed Pola's key challenges, including seizures, muscle tension, and light sensitivity. Despite the disruption caused by the COVID-19 lockdown, Pola's mother expressed her high satisfaction with the results and strongly recommended the treatment to others. They are also considering returning for further therapy to help Pola develop new skills. The expectation for the second treatment is further improvements in distance vision and object perception. Watch the full video to hear her family's insights.
Watch video →It's Ginevra's second stem cell treatment for Optic Nerve Hypoplasia/Septo Optic Dysplasia. After the first treatment, she experienced significant improvements in her visual and motor conditions over three months. Previously unable to perceive light, Ginevra can now follow it and has started to walk. According to her family, Beike's treatment—which included four lumbar and four intravenous injections supplemented with growth factor for nerve growth—was administered smoothly and with minimal pain by a professional nursing team. During the first round, Ginevra began to distinguish colors and take her first steps. The expectation for the second treatment is further improvements in distance vision and object perception. Watch the full video to hear her family's insights.
Watch video →Bernardo, an eight-year-old boy from Brazil, received his first stem cell therapy in April 2024 at one of our Thai partner facilities. Throughout his stay, his family graciously accepted our invitation to share their incredible journey. They discussed the difficulties they faced after discovering Bernardo's condition, their fundraising efforts, and the mix of hopes and fears they felt about the treatment. They also talked about the stem cell therapy process and the early improvements they saw in Bernardo's condition. Their story demonstrates resilience and hope, inspiring other families in similar situations.
Watch video →From your first inquiry to post-treatment follow-up —
we guide you every step of the way.
Tell us about your condition. Speak with our medical advisors — no obligation.
Our doctors review your medical records and recommend a tailored protocol.
Receive specialized stem cell therapy at our partner hospital, fully supervised.
We stay in touch and monitor your progress for the months that follow.
Talk to our medical team — no obligation, response within 48 hours.
Request consultationNo obligation. We’ll review your situation and respond within 48 hours.
Reviewed by the Beike medical advisory team — answering patient inquiries since 2005.